Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Philadelphia, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Carisma Therapeutics Inc. has filed 853 SEC EDGAR filings since 24 Feb 2010

SEC filing history

Showing 576-600 of 853 matching filings.

Per page
25
Current page
24
NT 10-Q File 001-36296

NT 10-Q

Filing date
15 Nov 2017
Reporting date
30 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87951

ELEVEN BIOTHERAPEUTICS, INC.

Filing date
08 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36296

8-K

Filing date
03 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-220809

424B4

Filing date
03 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-220809

EFFECT filing

Filing date
01 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-220809

S-1/A

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-220809

S-1/A

Filing date
30 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
23 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36296

8-K

Filing date
20 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-220809

FWP

Filing date
20 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36296

8-K/A

Filing date
18 Oct 2017
Reporting date
06 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-220809

S-1/A

Filing date
17 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36296

8-K

Filing date
13 Oct 2017
Reporting date
06 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-220809

S-1

Filing date
04 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36296

8-K

Filing date
22 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36296

8-K

Filing date
14 Aug 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36296

8-K

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
19 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .